Kidney (Renal Cell) Cancer
Featured Articles
(Regulatory Focus) June 25, 2018 - Scott Gottlieb, FDA Commissioner, said Monday at the National Press Club in Washington, DC that his agency will release a list of surrogate endpoints used in cancer drug development soon.
Read Article
(Yale News) May 10, 2018 - The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study.
Read Article
Latest Articles
July 11, 2018
July 10, 2018
July 05, 2018
June 26, 2018
June 22, 2018
June 20, 2018
June 14, 2018
June 12, 2018
View More
News Commentary
Editor Image
06 Mar, 2018 | by H. Jack West, MD
With the evidence on immune checkpoint inhibitors in many cancer settings being...
View Comment
Editor Image
19 Feb, 2018 | by Winston Wong, PharmD
I lived through and was part of the payer process for many years. It is not a...
View Comment
View More
Featured Videos
There are no videos.
OBR Blog
There are no Kidney (Renal Cell) Cancer blog entries.